Anticoagulant News and Research

RSS
Catheter ablation improves quality of life for adults with atrial fibrillation

Catheter ablation improves quality of life for adults with atrial fibrillation

New analysis provides information about which medications best after different types of surgery

New analysis provides information about which medications best after different types of surgery

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Study does not find association between HPV vaccination and increased risk of blood clot

Study does not find association between HPV vaccination and increased risk of blood clot

New strategy for treating neuroblastoma using modified version of heparin

New strategy for treating neuroblastoma using modified version of heparin

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

European Commission approves Boehringer Ingelheim's Pradaxa for prevention of DVT and PE

European Commission approves Boehringer Ingelheim's Pradaxa for prevention of DVT and PE

Registration now open for interactive one day workshop for GPs

Registration now open for interactive one day workshop for GPs

Anticoagulation therapy with low-dose aspirin can be used with new generation mechanical heart valve

Anticoagulation therapy with low-dose aspirin can be used with new generation mechanical heart valve

AFib patients who are on blood thinning medications are at higher risk of developing dementia

AFib patients who are on blood thinning medications are at higher risk of developing dementia

Ambrisentan cleared for use with phenprocoumon

Ambrisentan cleared for use with phenprocoumon

AstraZeneca’s EPANOVA receives FDA approval for treatment of adults with hypertriglyceridemia

AstraZeneca’s EPANOVA receives FDA approval for treatment of adults with hypertriglyceridemia

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva's SYNRIBO for injection receives FDA approval for home administration

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Biomedical engineer develops highly innovative technology to make blood transfusions safer

Biomedical engineer develops highly innovative technology to make blood transfusions safer

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.